SNPX: Neurotrope Kapitalizatsiyaning foydaga nisbati
Synaptogenix, Inc. (SNPX) sinapslar regeneratsiyasini o'rganish va Bryostatin-1 sinovlarini o'tkazish orqali demensiya terapiyalarini kashf etishga e'tibor qaratadi. Quyida keltirilgan kotirovkalar 0.00 darajasida qotirilgan. Shu bilan birga, Inertia anti-neyrodegeneratsiya agentlarini ishlab chiqmoqda, bu esa patentga egalik qilish davrida barqaror talabni ta'minlaydi. Biroq, biznes hozirda faqat kapitalni iste'mol qilmoqda va foyda keltiradigan operatsion daromad manbalariga ega emas.
Neurotrope (SNPX) kompaniyasining tahliliy kesimlari
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Jamlagan qarzning xususiy kapitalga nisbati Synaptogenix, Inc.|SNPX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati Synaptogenix, Inc|SNPX - Kompaniya qarzlari|Balans qiymatiga qarzlar Synaptogenix, Inc.|SNPX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik Synaptogenix|Shoshilinch likvidlik synaptogen.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
SNPX - Kompaniyaning sof foydasi|Sof foyda prognozi Synaptogenix, Inc.|SNPX - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Synaptogenix Inc.|SNPX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Synaptogenix, Inc.|SNPX - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Synaptogenix|SNPX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi synaptogen.com|SNPX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Synaptogenix, Inc.
Kompaniyaning har tomonlama tahlili:SNPX (synaptogen.com)
Synaptogenix, Inc. (SNPX) aktivlarini tahlil qilish bozor kutuvlarining aniq bahosini talab qiladi. Kompaniyaning fundamental P/E koeffitsiyenti joriy aksiya narxini yillik sof foyda bilan bog'lab, foyda birligi uchun narxni belgilaydi. Ushbu ko'rsatkichning o'sishi investorlarning biofarmatsevtika ishlanmalarining kelgusidagi muvaffaqiyatiga bo'lgan ishonchini anglatadi. ESG standartlari va bioetikaning samarali joriy etilishi operatsion xatarlarni kamaytirib, investitsiyalar jozibadorligini qo'llab-quvvatlaydi. Baholash barqarorligi kapitalning tashqi zarbalarga chidamliligini tasdiqlaydi.
Muhim raqobatchilar
biogen.com (BIIB) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NBIX (Neurocrine Biosciences, Inc.)|RGC - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|ACAD: Narx-foyda multiplikatori|Xenon Pharmaceuticals - P/E multiplikatori|VKTX - P/E multiplikatori|Supernus (SUPN) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati CPRX (Catalyst Pharma)|Narx-foyda koeffitsiyenti DNLI|HRMY (Harmony Corp) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Biohaven Ltd. (BHVN)|AMLX - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori TRVI (Trevi Therapeutics, Inc.)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Praxis Precision Medicines Inc|Anavex Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CeriBell EEG|prothena.com (PRTA) - Narxning foydaga nisbati|Narx-foyda multiplikatori ALEC|ANNX (Annexon) - P/E multiplikatori|Omeros Corp. (OMER) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NGNE (Neurogene Corp)|AC Immune Inc - Narx-foyda multiplikatori|Voyager Therapeutics - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati NMRA|Scilex - P/E multiplikatori|Biznesning o‘zini qoplash muddati Tevogen Bio Holdings Inc. TVGN|alphacognition.com (ACOG) - Narxning foydaga nisbati|Narx-foyda multiplikatori CGTX|IKT (Inhibikase Therapeutics) - P/E multiplikatori|Narx-foyda koeffitsiyenti cassavasciences.com (SAVA)|Narx-foyda koeffitsiyenti ASRT (Assertio Holdings, Inc.)|Biznesning o‘zini qoplash muddati coyatherapeutics.com|Narxning foydaga nisbati Vistagen VTGN|Biznesning o‘zini qoplash muddati Ovid Therapeutics Inc (OVID)|ABOS - Narxning foydaga nisbati|CRVO (cervomed.com) - Narx-foyda multiplikatori|alteritytherapeutics.com (ATHE) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati CLNN (Clene)|Narx-foyda koeffitsiyenti PEPG|Narx-foyda multiplikatori JUNS (Jupiter Neurosciences, Inc.)|Narxning foydaga nisbati Relmada Therapeutics (RLMD)|annovisbio.com - Narx-foyda multiplikatori|P/E multiplikatori GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Kapitalizatsiyaning foydaga nisbati|KLTO: Narx-foyda koeffitsiyenti|NRSN - P/E multiplikatori|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MetaVia - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati NeurAxis|Kapitalizatsiyaning foydaga nisbati Helius Medical Technologies Inc. HSDT|Narxning foydaga nisbati Passage Bio, Inc. (PASG)|Biznesning o‘zini qoplash muddati bionomics.com.au|Minerva Neurosciences - Narx-foyda koeffitsiyenti|athira.com (ATHA) - Kapitalizatsiyaning foydaga nisbati|ADXN - Narxning foydaga nisbati|ALZN (Alzamend Neuro, Inc.) - Narx-foyda multiplikatori|CYCN: P/E multiplikatori|Protagenic Therapeutics, Inc. (PTIX) - P/E multiplikatori|Narxning foydaga nisbati Pasithea Therapeutics Corp|Cortigent Medical - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ATXI (Avenue Therapeutics, Inc.)|Bozor narxining sof foydaga nisbati BCLI|Narxning foydaga nisbati Cara Therapeutics, Inc CARA|Chromocell (CHRO) - Kapitalizatsiyaning foydaga nisbati|Eliem - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Intra-Cellular Therapies (ITCI)|LBPH: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Marinus Pharmaceuticals Inc (MRNS)|Narxning foydaga nisbati NKGen|Narx-foyda multiplikatori NRBO (NeuroBo Pharma)|P/E multiplikatori SAGE|Biznesning o‘zini qoplash muddati trevena.com|Vigil Neuroscience, Inc. - Narx-foyda koeffitsiyenti|WENA: Narx-foyda multiplikatori|CERE: Narx-foyda koeffitsiyenti
